a

Integra LifeSciences Receives FDA Approval for Expanded Indications for Spine Device Featured

Written by  Jaimie Oh | October 09, 2012
Social sharing
Integra LifeSciences has received FDA approval for expanded indication for use of the Integra Vu aPOD Prime Intervertebral Body Fusion Device in anterior lumbar interbody fusion procedures.
The new stand-alone indication includes four points of fixation, which is composed of two screws and a SpinPlate. The Integra Vu aPOD Prime IBD features two zero-profile options utilizing two screws or two screws and a SpinPlate to help secure the IBD in its functional position, eliminating the need for supplemental fixation implants and reducing
the number of steps and implants required to perform an ALIF procedure.

More Articles on Orthopedic Devices:

Spinal Elements to Donate Allograft Proceeds to Charity

Medtronic Launches Complementary Instrument Set for BRYAN Cervical Disc

SkelRegen Forms With Focus on Musculoskeletal Care


© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.

blog comments powered by Disqus